| Value | ₹0.05 Cr |
|---|
BSE filing, BSE: 544440. Summary written from the filing by ALFA Finder's alert engine.
Cryogenic OGS Ltd: key numbers
- Share price
- ₹374.30
- Market cap
- ₹534.5 Cr
- Revenue (annual)
- ₹40.82 Cr
- Net profit (annual)
- ₹10.18 Cr
- P/E (TTM)
- 52.5×Sector 52.2×
- Promoter holding
- 74.29%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cryogenic OGS Ltd
All →Cryogenic OGS Board Meeting Date
Cryogenic OGS will hold a board meeting on 29 October 2026 to consider unaudited half-year results. The results are not yet approved, so this is advance notice only.
Cryogenic OGS Other Announcement
Cryogenic Ogs Ltd filed its quarterly shareholding pattern as mandated by Regulation 31(1)(b) for the period ending September 30, 2026.
Cryogenic OGS Business Update
Cryogenic Ogs received an enlistment approval from ADNOC for Industrial Strainers, becoming an approved vendor. This enables participation in ADNOC tenders and strengthens international market presence.
Cryogenic OGS Bags ₹5.08 Cr Order from International MNC specialising in Industrial Process Engineering
Cryogenic OGS Ltd received a Rs. 5.08 Crore order from an international MNC for supplying metering skids. Execution is scheduled within 12–20 weeks.
- Value
- ₹5.08 Cr
- From
- International MNC specialising in Industrial Process Engineering
- Execution
- 12 – 20 Weeks
Cryogenic OGS Bags ₹19.36 Cr Order from Global EPC Company
Cryogenic OGS received its first independent export order of USD 2,022,816 (~₹19.36 Cr) from a Global EPC company for Piping Spools. Execution is scheduled within 12–20 weeks.
- Value
- ₹19.36 Cr
- From
- Global EPC Company (bulk liquid storage terminals, refineries, oil & gas process plants)
- Execution
- 12–20 weeks
Cryogenic OGS Annual General Meeting
Cryogenic OGS Limited held its 29th Annual General Meeting on August 20, 2026, covering financial results, director re-appointment, and related party transaction approvals.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr